Alkem Laboratories Limited, a leading pharmaceutical company in India, announced a strategic investment of ₹30,00,05,156 in HaystackAnalytics Private Limited. This pre-Series A investment signifies Alkem’s commitment to harnessing the power of advanced genomic data analysis for improved diagnostics and business growth. Aligning with Growth Strategies The investment falls outside the purview of related party transactions. …